Targeting of peptide conjugated magnetic nanoparticles to urokinase plasminogen activator receptor (uPAR) expressing cells

Nanoscale

Volumn 5, Issue 17, 2013, Pages 8192-8201

  Hansen, Line ^a   Unmack Larsen, Esben Kjær ^a   Nielsen, Erik Holm ^b   Iversen, Frank ^a   Liu, Zhuo ^a,e   Thomsen, Karen ^a   Pedersen, Michael ^c   Skrydstrup, Troels ^b   Nielsen, Niels Chr ^b   Ploug, Michael ^d,e   Kjems, Jørgen ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

^e Danish Chinese Centre for Proteases and Cancer   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLICK CHEMISTRY; MAGNETIC NANO-PARTICLES; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; PATIENT PROGNOSIS; POLYETHYLENE GLYCOL (PEG); TARGETING PEPTIDES; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UROKINASE PLASMINOGEN;

CELL CULTURE; DIAGNOSIS; DISEASES; DRUG DELIVERY; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; PEPTIDES; SUPERPARAMAGNETISM;

NANOPARTICLES;

FERRIC ION; FERRIC OXIDE; FLUORESCENT DYE; MACROGOL DERIVATIVE; MAGNETITE NANOPARTICLE; PEPTIDE; UROKINASE RECEPTOR; PROTEIN BINDING;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN HEK293; CHEMISTRY; CLICK CHEMISTRY; CONFOCAL MICROSCOPY; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING; SYNTHESIS; ANTAGONISTS AND INHIBITORS; HEK293 CELL LINE;

AMINO ACID SEQUENCE; CLICK CHEMISTRY; FERRIC COMPOUNDS; FLUORESCENT DYES; HEK293 CELLS; HUMANS; MAGNETITE NANOPARTICLES; MICROSCOPY, CONFOCAL; PEPTIDES; POLYETHYLENE GLYCOLS; PROTEIN BINDING; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84881501276     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c3nr32922d     Document Type: Article

References (43)

1. N. Hyon Bin S. In Chan H. Taeghwan Inorganic Nanoparticles for MRI Contrast Agents Adv. Mater. 2009 21 21 2133 2148
2. T. Wittenborn et al., Ultrahigh-field DCE-MRI of angiogenesis in a novel angiogenesis mouse model Journal of Magnetic Resonance Imaging 2012 35 3 703 710
3. E. K. U. Larsen et al., Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors Nanoscale 2012 4 7 2352 2361
4. J. R. McCarthy R. Weissleder Multifunctional magnetic nanoparticles for targeted imaging and therapy Adv. Drug Delivery Rev. 2008 60 11 1241 1251
5. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 2005 5 3 161 171
6. M. Jo et al., The Urokinase Receptor Promotes Cancer Metastasis Independently of Urokinase-Type Plasminogen Activator in Mice Am. J. Pathol. 2009 175 1 190 200
7. M. Kriegbaum et al., Rational targeting of the urokinase receptor (uPAR): Development of antagonists and non-invasive imaging probes Curr. Drug Targets 2011 12 1711 1728
8. I. K. Lund et al., uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy Curr. Drug Targets 2011 12 12 1744 1760
9. L. Yang et al., Molecular Imaging of Pancreatic Cancer in an Animal Model Using Targeted Multifunctional Nanoparticles Gastroenterology 2009 136 5 1514.e2 1525.e2
10. L. Yang et al., Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer Clin. Cancer Res. 2009 15 14 4722 4732
11. J. A. Joyce J. W. Pollard Microenvironmental regulation of metastasis Nat. Rev. Cancer 2009 9 4 239 252
12. H. W. Smith C. J. Marshall Regulation of cell signalling by uPAR Nat. Rev. Mol. Cell Biol. 2010 11 1 23 36
13. M. Ploug et al., Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl- phosphatidylinositol J. Biol. Chem. 1991 266 3 1926 1933
14. H. Gårdsvoll et al., Conformational Regulation of Urokinase Receptor Function J. Biol. Chem. 2011 286 38 33544 33556
15. H. Gårdsvoll et al., Mimicry of the Regulatory Role of Urokinase in Lamellipodia Formation by Introduction of a Non-native Interdomain Disulfide Bond in Its Receptor J. Biol. Chem. 2011 286 50 43515 43526
16. P. Llinas et al., Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide EMBO J. 2005 24 9 1655 1663
17. P. A. Andreasen R. Egelund H. H. Petersen The plasminogen activation system in tumor growth, invasion, and metastasis Cell. Mol. Life Sci. 2000 57 1 25 40
18. T. J. D. Jørgensen et al., Dynamics of Urokinase Receptor Interaction with Peptide Antagonists Studied by Amide Hydrogen Exchange and Mass Spectrometry Biochemistry 2004 43 47 15044 15057
19. C. D. Hein X. M. Liu D. Wang Click chemistry, a powerful tool for pharmaceutical sciences Pharm. Res. 2008 25 10 2216 2230
20. P.-C. Lin et al., Surface Modification of Magnetic Nanoparticle via Cu(i)-Catalyzed Alkyne-Azide [2 + 3] Cycloaddition Org. Lett. 2007 9 11 2131 2134
21. N. V. Voigt et al., Single-molecule chemical reactions on DNA origami Nat. Nanotechnol. 2010 5 3 200 203
22. B. Qualmann et al., Synthesis of Boron-Rich Lysine Dendrimers as Protein Labels in Electron Microscopy Angew. Chem., Int. Ed. Engl. 1996 35 8 909 911
23. W. C. Chan and P. D. White, Fmoc Solid Phase Peptide Synthesis: A Practical Approach The Practical Approach Series, ed., B. D. Hames, Oxford University Press, 2000
24. T. Hillig et al., A Composite Role of Vitronectin and Urokinase in the Modulation of Cell Morphology upon Expression of the Urokinase Receptor J. Biol. Chem. 2008 283 22 15217 15223
25. G. Zhao et al., Protein expression and preliminary crystallographic analysis of amino-terminal fragment of urokinase-type plasminogen activator Protein Expression Purif. 2006 49 1 71 77
26. M. Ploug et al., Peptide-Derived Antagonists of the Urokinase Receptor. Affinity Maturation by Combinatorial Chemistry, Identification of Functional Epitopes, and Inhibitory Effect on Cancer Cell Intravasation Biochemistry 2001 40 40 12157 12168
27. E. K. U. Larsen et al., Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors ACS Nano 2009 3 7 1947 1951
28. H. C. Kolb M. G. Finn K. B. Sharpless Click Chemistry: Diverse Chemical Function from a Few Good Reactions Angew. Chem., Int. Ed. 2001 40 11 2004 2021
29. M. F. Jacobsen J. B. Ravnsbaek K. V. Gothelf Small molecule induced control in duplex and triplex DNA-directed chemical reactions Org. Biomol. Chem. 2010 8 1 50 52
30. T. R. Chan et al., Polytriazoles as Copper(i)-Stabilizing Ligands in Catalysis Org. Lett. 2004 6 17 2853 2855
31. R. K. O'Reilly et al., Facile syntheses of surface-functionalized micelles and shell cross-linked nanoparticles J. Polym. Sci., Part A: Polym. Chem. 2006 44 17 5203 5217
32. M. Meldal C. W. Tornøe Cu-Catalyzed Azide-Alkyne Cycloaddition Chem. Rev. 2008 108 8 2952 3015
33. H. B. Na I. C. Song T. Hyeon Inorganic Nanoparticles for MRI Contrast Agents Adv. Mater. 2009 21 21 2133 2148
34. G. Simon et al., T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5 T and 3 T clinical MR scanning Eur. Radiol. 2006 16 3 738 745
35. G. Hermanson, Bioconjugate Techniques 2nd edition, Academic Press, Elsevier, 2008
36. T. Scheibel Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins Microb. Cell Fact. 2004 3 1 14
37. F. Gu et al., Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers Proc. Natl. Acad. Sci. U. S. A. 2008 105 7 2586 2591
38. H. A. Chapman et al., Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface Am. J. Physiol.: Lung Cell. Mol. Physiol. 1990 259 6 L432 L438
39. R. C. Haddock et al., Urokinase binding and receptor identification in cultured endothelial cells J. Biol. Chem. 1991 266 32 21466 21473
40. H. McNeill P. Jensen A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration Cell. Regul. 1990 1 11 843
41. P. Mignatti R. Mazzieri D. B. Rifkin Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor J. Cell Biol. 1991 113 5 1193 1201
42. Z.-B. Li et al., Imaging of Urokinase-Type Plasminogen Activator Receptor Expression Using a 64Cu-Labeled Linear Peptide Antagonist by microPET Clin. Cancer Res. 2008 14 15 4758 4766
43. M. Persson et al., Quantitative PET of Human Urokinase-Type Plasminogen Activator Receptor with 64Cu-DOTA-AE105: Implications for Visualizing Cancer Invasion J. Nucl. Med. 2012 53 1 138 145